Vaccines Market 2018-2025 | Extensive Analysis On Worldwide Industry and New Market Opportunities.
Meticulous
Research®, leading global market research company published a research report
titled, “The Global Vaccines Market is
projected to $57.50 billion by 2025 growing at a CAGR of 7.9% during the
forecast period of 2018 to 2025.”
The Global Vaccines Market study presents historical market data in terms of
values (2016 and 2017), estimated current data (2018), and forecasts for
2025-Vaccines Market By Indication (Pneumococcal, Influenza, DTP, HPV,
Hepatitis, Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route Of
Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography.
In 2017, the pneumococcal disease
accounted for the largest share of the global vaccines market. The large share
of this segment is mainly attributed to the high prevalence of pneumococcal
disease in pediatric, elderly, and immunocompromised populations. In addition,
growing number of pneumococcal diseases associated with chronic disease
patients is further driving the adoption of pneumococcal vaccines. However,
meningococcal disease vaccine segment is expected to grow at the highest CAGR
in the next 5-7 years.
The growth of this market is mainly attributed
to high prevalence of diseases, increasing government initiatives towards
immunization, rising adoption of vaccines, technological advancement in vaccine
industry, and strong pipeline for vaccines.
The global vaccines market is
highly competitive with the presence of many players worldwide. With four big
pharmaceutical companies; GSK, Merck & Co., Inc., Pfizer, and Sanofi, the
vaccine industry is highly consolidated. CSL Limited, Emergent BioSolutions,
Johnson and Johnson, Serum Institute of India, Daiichi Sankyo, Takeda and
AstraZeneca are the other leading players of the global vaccines market. All these
players are focusing more on technologically-advanced vaccine products.
Read full Research Report Study On
North America accounted for the
largest share of the vaccines market with its well-established vaccination
program. In addition, factors such as the increasing prevalence of diseases,
growing adoption of advanced vaccines, and large pool of key players are
further expected to propel the growth of vaccines market in this region.
The intramuscular accounted for the
largest share of the vaccines market. The large share of this segment is mainly
due to the availability of wide range of vaccines for IM.
Key Topics Covered in This Report:
1.
Introduction
2.
Research Methodology
3.
Executive Summary
4.
Market Share Analysis
5.
Market Insights
6.
Global Vaccines Market, by Indication
7.
Global Vaccines Market, by Route of Administration
8.
Global Vaccines Market, by Type/Antigen
9.
Global Vaccines Market, by Valence
10. Vaccines Market, by Region
11. Competitive Landscape
12. Company Profiles
13. Appendix
Hurry Up To Get Your Free Sample Report Now!
The Asia-Pacific vaccines market is
expected to grow at the highest CAGR of 8.9%. The growth in the APAC market is
mainly attributed to large patient pool, rising prevalence of diseases, growing
awareness on vaccination, increasing government initiatives, and expanding
presence of key players in this region. In addition, increasing disposable
income and growing awareness about heath in emerging countries are further
propelling the demand for vaccines in APAC region.
Contact
-
Viren Shrivastava
Email: viren@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)
No comments:
Post a Comment